Coherus BioSciences Relocates Principal Executive Offices
Ticker: CHRS · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1512762
Sentiment: neutral
Topics: corporate-action, filing
TL;DR
Coherus BioSciences moved its HQ to Redwood City, CA.
AI Summary
On March 4, 2025, Coherus BioSciences, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065. This move is part of the company's ongoing operations and reporting requirements.
Why It Matters
This filing signals a physical relocation of Coherus BioSciences' main operational hub, which could impact logistics, employee location, and potentially future expansion plans.
Risk Assessment
Risk Level: low — The filing solely reports a change of address for the principal executive offices, which is a routine administrative event with no immediate financial or operational risk.
Key Players & Entities
- Coherus BioSciences, Inc. (company) — Registrant
- 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065 (location) — New Principal Executive Offices
- Dennis M. Lanfear (person) — Contact Person for Business and Mail Address
FAQ
What is the new address for Coherus BioSciences' principal executive offices?
The new address is 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065.
When was this change of address reported?
The change was reported on March 4, 2025.
What is the IRS Employer Identification Number for Coherus BioSciences?
The IRS Employer Identification Number is 27-3615821.
In which state is Coherus BioSciences incorporated?
Coherus BioSciences is incorporated in Delaware.
What was the former name of Coherus BioSciences?
The former name was BioGenerics, Inc., with a name change date of February 10, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 by Dennis M. Lanfear regarding Coherus BioSciences, Inc. (CHRS).